Evolent Health (EVH) Given Daily Media Impact Rating of 0.24

News coverage about Evolent Health (NYSE:EVH) has been trending somewhat positive on Saturday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Evolent Health earned a daily sentiment score of 0.24 on Accern’s scale. Accern also assigned news stories about the technology company an impact score of 47.6805450894185 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Evolent Health (EVH) opened at $14.60 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.85 and a quick ratio of 2.85. The company has a market cap of $1,146.07, a PE ratio of -14.90 and a beta of 1.08. Evolent Health has a one year low of $10.30 and a one year high of $27.50.

Several equities analysts recently commented on EVH shares. Canaccord Genuity cut their price target on shares of Evolent Health from $27.00 to $24.00 and set a “buy” rating on the stock in a report on Wednesday, February 28th. Jefferies Group set a $22.00 price target on shares of Evolent Health and gave the company a “buy” rating in a report on Tuesday, February 13th. Citigroup assumed coverage on shares of Evolent Health in a research note on Thursday, January 4th. They issued a “buy” rating on the stock. Cantor Fitzgerald restated a “buy” rating and issued a $30.00 target price on shares of Evolent Health in a research note on Sunday, December 3rd. Finally, Leerink Swann set a $25.00 target price on shares of Evolent Health and gave the stock a “buy” rating in a research note on Saturday, November 18th. Three analysts have rated the stock with a sell rating and twelve have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $25.33.

In other Evolent Health news, Director Unitedhealth Group Inc sold 3,040,000 shares of the company’s stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $13.70, for a total value of $41,648,000.00. The sale was disclosed in a filing with the SEC, which is available through this link. 8.79% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: “Evolent Health (EVH) Given Daily Media Impact Rating of 0.24” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/03/17/evolent-health-evh-given-daily-media-impact-rating-of-0-24.html.

About Evolent Health

Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.

Insider Buying and Selling by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply